Next generation sequencing techniques and newborn screenings: governing innovation
Tomasi, Marta.
Rev. derecho genoma hum
; (45): 143-158, jul.-dic. 2016.
Artículo en Inglés | IBECS (España) | ID: ibc-193093
Documentos relacionados
Challenging the dogma of the healthy heterozygote: Implications for newborn screening policies and practices.
Cystic fibrosis carrier screening.
Carrier testing in minors: conflicting views.
How should severity be understood in the context of reproductive genetic carrier screening?
Technical factors to consider when developing an Expanded Carrier Screening platform.
Carrier frequency estimation of Zellweger spectrum disorder using ExAC database and bioinformatics tools.
Experience with Parent Follow-Up for Communication Outcomes after Newborn Screening Identifies Carrier Status.
Diagnostic problems in cystic fibrosis - specific characteristics of a group of infants and young children diagnosed positive through neonatal screening, in whom cystic fibrosis had not been diagnosed.
Impairment Experiences, Identity and Attitudes Towards Genetic Screening: the Views of People with Spinal Muscular Atrophy.
Ethnically unique disease burden and limitations of current expanded carrier screening panels.